Delivery Order SPE2DB22D3004-SPE2DB25FPX71

Award Date 3/14/25
Potential Completion Date 3/17/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of epinephrine 0.3 mg auto-injectors in a quantity of 2 per package. The $8,799.04 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that supplies medical products to military treatment facilities. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The $2,067.08 firm fixed price award is for the supply of 4,565,215,508 units of Epinephrine 0.3 mg auto-injectors. The contract has an ultimate completion date of July 22, 2024. Amerisourcebergen, through its Corporate Office division, has been a significant provider of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA) Troop Support Medical. The $12,486.95 delivery order contract is a firm fixed-price agreement with an ultimate completion date of January 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $1,547.00, is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 5, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,437.75 delivery order is for the supply of Epinephrine 0.3 mg auto-injector devices, which are critical medical supplies used to treat severe allergic reactions. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,607.96 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA that provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC with the DLA,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical devices. The $1,495.30 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on July 5, 2024 with a completion date of July 8, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides medical products and supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,388.17 Firm Fixed Price delivery order covers the procurement of epinephrine 0.3 mg auto-injectors, with an ultimate completion date of February 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a $20,108.46 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the delivery of 4566026543 EPINEPHRINE 0.3 MG AUTO-INJECT 2S, with a completion date of October 7, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical, which enables the agency...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product. The contract is a Delivery Order with a Firm Fixed Price of $1,113.77 and has an ultimate completion date of February 19, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) between...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPX71
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical products to the Defense Logistics Agency (DLA). The Firm Fixed Price delivery order, valued at $1,008.38, has a completion date of March 17, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/13/25, 10:04 AM